Literature DB >> 19067071

Measurement of gastric pH in ambulatory esophageal pH monitoring.

Shahin Ayazi1, Jessica M Leers, Arzu Oezcelik, Emmanuele Abate, Christian G Peyre, Jeffrey A Hagen, Steven R DeMeester, Farzaneh Banki, John C Lipham, Tom R DeMeester, Peter F Crookes.   

Abstract

BACKGROUND: Ambulatory esophageal pH monitoring is the method used most widely to quantify gastroesophageal reflux. The degree of gastroesophageal reflux may potentially be underestimated if the resting gastric pH is high. Normal subjects and symptomatic patients undergoing 24-h pH monitoring were studied to determine whether a relationship exists between resting gastric pH and the degree of esophageal acid exposure.
METHODS: Normal volunteers (n = 54) and symptomatic patients without prior gastric surgery and off medication (n = 1,582) were studied. Gastric pH was measured by advancing the pH catheter into the stomach before positioning the electrode in the esophagus. The normal range of gastric pH was defined from the normal subjects, and the patients then were classified as having either normal gastric pH or hypochlorhydria. Esophageal acid exposure was compared between the two groups.
RESULTS: The normal range for gastric pH was 0.3-2.9. The median age of the 1,582 patients was 51 years, and their median gastric pH was 1.7. Abnormal esophageal acid exposure was found in 797 patients (50.3%). Hypochlorhydria (resting gastric pH >2.9) was detected in 176 patients (11%). There was an inverse relationship between gastric pH and esophageal acid exposure (r = -0.13). For the patients with positive 24-h pH test results, the major effect of gastric pH was that the hypochlorhydric patients tended to have more reflux in the supine position than those with normal gastric pH.
CONCLUSION: There is an inverse, dose-dependent relationship between gastric pH and esophageal acid exposure. Negative 24-h esophageal pH test results for a patient with hypochlorhydria may prompt a search for nonacid reflux as the explanation for the patient's symptoms.

Entities:  

Mesh:

Year:  2008        PMID: 19067071     DOI: 10.1007/s00464-008-0218-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  13 in total

1.  Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole.

Authors:  M F Vela; L Camacho-Lobato; R Srinivasan; R Tutuian; P O Katz; D O Castell
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects.

Authors:  E J Prewett; J T Smith; C U Nwokolo; A M Sawyerr; R E Pounder
Journal:  Clin Sci (Lond)       Date:  1991-06       Impact factor: 6.124

3.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

4.  Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists.

Authors:  C J Fimmel; A Etienne; T Cilluffo; C von Ritter; T Gasser; J P Rey; P Caradonna-Moscatelli; F Sabbatini; F Pace; H W Bühler
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

5.  My approach to the difficult GERD patient.

Authors:  D Castell
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-06       Impact factor: 2.566

6.  Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.

Authors:  Frank Zerbib; Sabine Roman; Alain Ropert; Stanislas Bruley des Varannes; Philippe Pouderoux; Ulriikka Chaput; François Mion; Eric Vérin; Jean-Paul Galmiche; Daniel Sifrim
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

7.  The burden of gastrointestinal and liver diseases, 2006.

Authors:  Nicholas J Shaheen; Richard A Hansen; Douglas R Morgan; Lisa M Gangarosa; Yehuda Ringel; Michelle T Thiny; Mark W Russo; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2006-07-18       Impact factor: 10.864

Review 8.  Therapy of gastroesophageal reflux: evidence-based approach to antireflux surgery.

Authors:  Lars Lundell
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

9.  Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.

Authors:  L P Leite; R J Just; D O Castell; P O Lagerström
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

Review 10.  Ambulatory 24-hour esophageal pH monitoring: why, when, and what to do.

Authors:  Christopher G Streets; Tom R DeMeester
Journal:  J Clin Gastroenterol       Date:  2003-07       Impact factor: 3.062

View more
  13 in total

1.  Thoraco-abdominal pressure gradients during the phases of respiration contribute to gastroesophageal reflux disease.

Authors:  Shahin Ayazi; Steven R DeMeester; Chih-Cheng Hsieh; Joerg Zehetner; Gaurav Sharma; Kimberly S Grant; Daniel S Oh; John C Lipham; Jeffrey A Hagen; Tom R DeMeester
Journal:  Dig Dis Sci       Date:  2011-04-22       Impact factor: 3.199

2.  Loss of alkalization in proximal esophagus: a new diagnostic paradigm for patients with laryngopharyngeal reflux.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Joerg Zehetner; Matt Lilley; Priyanka Wali; Florian Augustin; Arzu Oezcelik; Helen J Sohn; John C Lipham; Steven R Demeester; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-09-11       Impact factor: 3.452

3.  Intraluminal pH and goblet cell density in Barrett's esophagus.

Authors:  Dimitrios Theodorou; Shahin Ayazi; Steven R DeMeester; Joerg Zehetner; Christian G Peyre; Kimberly S Grant; Florian Augustin; Daniel S Oh; John C Lipham; Parakrama T Chandrasoma; Jeffrey A Hagen; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2011-11-18       Impact factor: 3.452

4.  Effect of Helicobacter pylori infection on symptoms of gastroenteritis due to enteropathogenic Escherichia coli in adults.

Authors:  Alicia Hsin-Ming Chang; Thomas Dean Haggerty; Catherine de Martel; Cynthia Wai-Mun Leung; Julie Parsonnet
Journal:  Dig Dis Sci       Date:  2010-07-16       Impact factor: 3.199

5.  The value of high-resolution manometry in the assessment of the resting characteristics of the lower esophageal sphincter.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Joerg Zehetner; Oliver Ross; Calvin Wu; Arzu Oezcelik; Emmanuele Abate; Helen J Sohn; Farzaneh Banki; John C Lipham; Steven R DeMeester; Tom R Demeester
Journal:  J Gastrointest Surg       Date:  2009-09-25       Impact factor: 3.452

6.  Esophageal intraepithelial eosinophils in dysphagic patients with gastroesophageal reflux disease.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Parakrama Chandrasoma; Parviz Gholami; Joerg Zehetner; Arzu Oezcelik; John C Lipham; Steven R Demeester; Tom R Demeester; Michael M Kline
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

7.  Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.

Authors:  Shahin Ayazi; Jeffrey A Hagen; Joerg Zehetner; Farzaneh Banki; Florian Augustin; Ali Ayazi; Steven R DeMeester; Daniel S Oh; Helen J Sohn; John C Lipham; Tom R DeMeester
Journal:  Surg Endosc       Date:  2011-02-27       Impact factor: 4.584

8.  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects.

Authors:  Yuuichi Sakurai; Akira Nishimura; Gale Kennedy; Mark Hibberd; Richard Jenkins; Hiroyuki Okamoto; Tomoki Yoneyama; Helen Jenkins; Kiyoshi Ashida; Shin Irie; Jörg Täubel
Journal:  Clin Transl Gastroenterol       Date:  2015-06-25       Impact factor: 4.488

9.  Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Asako Ito; Kyoko Arahata; Sakiko Takarabe; Shogo Kaida; Takanori Kanai; Soichiro Miura; Jiro Nishida
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

10.  Integration of mechanistic and pharmacokinetic information to derive oral reference dose and margin-of-exposure values for hexavalent chromium.

Authors:  Chad M Thompson; Christopher R Kirman; Sean M Hays; Mina Suh; Seneca E Harvey; Deborah M Proctor; Julia E Rager; Laurie C Haws; Mark A Harris
Journal:  J Appl Toxicol       Date:  2017-10-24       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.